Back to User profile » Dr Jun Nakamura
Papers published by Dr Jun Nakamura:
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Adding metoclopramide to paroxetine induced extrapyramidal symptoms and hyperprolactinemia in a depressed woman: a case report
Igata R, Hori H, Atake K, Katsuki A, Nakamura J
Neuropsychiatric Disease and Treatment 2016, 12:2279-2281
Published Date: 1 September 2016
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Catechol-O-methyltransferase Val158Met genotype and the clinical responses to duloxetine treatment or plasma levels of 3-methoxy-4-hydroxyphenylglycol and homovanillic acid in Japanese patients with major depressive disorder
Atake K, Yoshimura R, Hori H, Katsuki A, Nakamura J
Neuropsychiatric Disease and Treatment 2015, 11:967-974
Published Date: 3 April 2015
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Plasma levels of 3-methoxy-4-hydroxyphenylglycol are associated with microstructural changes within the cerebellum in the early stage of first-episode schizophrenia: a longitudinal VBM study
Nishimura J, Kakeda S, Abe O, Yoshimura R, Watanabe K, Goto N, Hori H, Sato T, Takao H, Kabasawa H, Nakamura J, Korogi Y
Neuropsychiatric Disease and Treatment 2014, 10:2315-2323
Published Date: 8 December 2014
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
A successful case of dose reduction in etizolam dependence using fine granules: a case report
Nishii S, Hori H, Kishimoto T, Nakamura J
International Medical Case Reports Journal 2014, 7:121-122
Published Date: 21 August 2014
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
COMT Val158Met, but not BDNF Val66Met, is associated with white matter abnormalities of the temporal lobe in patients with first-episode, treatment-naïve major depressive disorder: a diffusion tensor imaging study
Hayashi K, Yoshimura R, Kakeda S, Kishi T, Abe O, Umene-Nakano W, Katsuki A, Hori H, Ikenouchi-Sugita A, Watanabe K, Ide S, Ueda I, Moriya J, Iwata N, Korogi Y, Kubicki M, Nakamura J
Neuropsychiatric Disease and Treatment 2014, 10:1183-1190
Published Date: 25 June 2014
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Effect of blonanserin on cognitive and social function in acute phase Japanese schizophrenia compared with risperidone
Hori H, Yamada K, Kamada D, Shibata Y, Katsuki A, Yoshimura R, Nakamura J
Neuropsychiatric Disease and Treatment 2014, 10:527-533
Published Date: 26 March 2014